Basic Coagulation Profiles and Platelet Parameters Among Adult Type 1 and Type 2 Diabetes Patients at Dessie Referral Hospital, Northeast Ethiopia: Comparative Cross-Sectional Study

References

• International Diabetes Federation. Diabetes Atlas. sixth edition, 2013. Available from: http://www.diabetesatlas.org. Accessed November 10, 2018.
   Google Scholar
• Gundogan K, Bayram F, Capak M, Tanriverdi F, Karaman A. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Metab Syndr Relat Disord. 2009;7:427–434. doi:10.1089/met.2008.0068
   PubMed Web of Science ®Google Scholar
• Sobczak, Amélie IS, Alan SJ. Coagulatory Defects in Type-1 and Type-2 Diabetes. Int J Mol Sci. 2019;20:6345. doi:10.3390/ijms20246345
   Web of Science ®Google Scholar
• Odegaard AO, Jacobs DR, Sanchez OA, Goff DC, Reiner AP, Gross MD. Oxidative stress, inflammation, endothelial dysfunction, and incidence of type 2 diabetes. Cardiovasc Diabetol. 2016;15(1):51. doi:10.1186/s12933-016-0369-6
   PubMed Web of Science ®Google Scholar
• Soedamah-Muthu SS, Chaturvedi N, Toeller M, et al. Risk Factors for Coronary Heart Disease in Type 1 Diabetic Patients in Europe: the Eurodiab Prospective Complications Study. Diab Care. 2004;27(2):530–537. doi:10.2337/diacare.27.2.530
   PubMed Web of Science ®Google Scholar
• Kendall DM, Harmel AP. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. Am J Manag Care. 2002;8(20 Suppl):S635–S653.
   Web of Science ®Google Scholar
• Yngen DM. Platelet Hyperactivity in Diabetes Mellitus. Eur Cardiol Rev. 2005;1(1):1–5. doi:10.15420/ECR.2005.1o
   Google Scholar
• Wou C, Unwin N, Huang Y, Roglic G. Implications of the growing burden of diabetes for premature cardiovascular disease mortality and the attainment of the Sustainable Development Goal target. Cardiovasc Diagn Ther. 2019;9(2):140–149. doi:10.21037/cdt.2018.09.04
   Web of Science ®Google Scholar
• Use of glycated hemoglobin. (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract. 2011;93(3):299–309. doi:10.1016/j.diabres.2011.03.012
   Web of Science ®Google Scholar
• Fattah MA, Shaheen MH, Mahfouz MH. Disturbances of Haemostasis in Diabetes Mellitus. Dis Markers. 2004;19(6):251–258. doi:10.1155/2004/797458
   Web of Science ®Google Scholar
• Grant PJ. Diabetes mellitus as a prothrombotic condition. J Intern Med. 2007;262(2):157–172. doi:10.1111/j.1365-2796.2007.01824.x
   PubMed Web of Science ®Google Scholar
• Carr ME. Diabetes mellitus A hypercoagulable states. J Diabetes Complications. 2001;15(11):44–54. doi:10.1016/S1056-8727(00)00132-X
   Web of Science ®Google Scholar
• Kim JH, Bae HY, Kim SY. Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus.Diabetes. Metab J. 2013;37(6):423–428. doi:10.4093/dmj.2013.37.6.423
   Google Scholar
• Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diab Care. 1993;16:434–444. doi:10.2337/diacare.16.2.434
   PubMed Web of Science ®Google Scholar
• Vazzana N, Ranalli P, Cuccurullo C, Davì G. Diabetes mellitus and thrombosis. Thromb Res. 2012;129(3):371–377. doi:10.1016/j.thromres.2011.11.052
   PubMed Web of Science ®Google Scholar
• Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JCM, Hoekstra JBL. Hyperglycemia: a prothrombotic factor?: hyperglycemia and hypercoagulability. J Thromb Haemost. 2010;8(8):1663–1669. doi:10.1111/j.1538-7836.2010.03910.x
   PubMed Web of Science ®Google Scholar
• Byberg L, Siegbahn A, Berglund L, McKeigue P, Reneland R, Lithell H. Plasminogen Activator Inhibitor-1 Activity Is Independently Related to Both Insulin Sensitivity and Serum Triglycerides. Arterioscler Thromb Vasc Biol. 1998;18(2):258–264. doi:10.1161/01.ATV.18.2.258
   Web of Science ®Google Scholar
• Alzahrani S, Ajjan R. Review article on coagulation and fibrinolysis in diabetes. Diab Vasc Dis Res. 2010;7(4):260–273. doi:10.1177/1479164110383723
   PubMed Web of Science ®Google Scholar
• Ulutas KT, Dokuyucu R, Sefil F, et al. Evaluation of mean platelet volume in patients with type 2 diabetes mellitus and blood glucose regulation: a marker for atherosclerosis? Int J Clin Exp Med. 2014;7(4):955–961.
   PubMed Web of Science ®Google Scholar
• Sapkota B, Shrestha S, Poudel S. Association of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus. BMC Res Notes. 2013;6:485. doi:10.1186/1756-0500-6-485
   Google Scholar
• Erem C, Hacıhasanoğlu A, Ş Ç, et al. Coagulation and Fibrinolysis Parameters in Type 2 Diabetic Patients with and without Diabetic Vascular Complications. Med Princ Pract. 2005;14(1):22–30. doi:10.1159/000081919
   PubMed Web of Science ®Google Scholar
• Abdulla AM, Elmissbah TE, Hamid EM, A-ltom FO, Faisal M. Assessment of Coagulation Process in Diabetic Patients using Prothrombin Time and Activated Thromboplastin Time Tests. Int J Multidiscip Curr Res. 2017;4(3):84–88.
   Google Scholar
• Fadairo JK, Atere AD, Odunayo T, Abiodun OP. Assessment of Some Coagulation Indices among Type II Diabetic Subjects in a Tertiary Facility in South West Region, Nigeria. IOSR J Dent Med Sci:. 2016;15(6):159–163.
   Google Scholar
• Thukral S, Hussain S, Bhat S, Kaur N, Reddy A. Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) in Type 2 Diabetes Mellitus, a Case-Control Study. Diab Mellit. 2018;5(8):H5–H9.
   Google Scholar
• Banini AE, Boyd LC, Hoffman M. Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes. J Thromb Haemost. 2007;5(3):638–639. doi:10.1111/j.1538-7836.2007.02366.x
   Web of Science ®Google Scholar
• Awuku YA, Adu P, Ampomah LTW, et al. High risk of coagulopathy among Type-2 Diabetes Mellitus clients at a municipal hospital in Ghana. Ghana Med J. 2017;51(3):101–107. doi:10.4314/gmj.v51i3.2
   Google Scholar
• George LA, Lambert MP. Coagulation Cascade and Fibrinolysis Pathway: Assessment In Nonmalignant Hematology. Cham: Springer International Publisher; 2016:221–233.
   Google Scholar
• Swaminathan A, Amitkumar K, Ganapathy S, Ayyavoo S. Evaluation of mean platelet volume and other platelet parameters in subjects with Type-2 diabetes mellitus. Natl J Physiol Pharm Pharmacol. 2017;7(1):51–54. doi:10.5455/njppp.2016.6.0719518072016
   Google Scholar
• Wilson Van Voorhis CR, Morgan BL. Understanding Power and Rules of Thumb for Determining Sample Sizes. Tutor Quant Methods Psychol. 2007;3(2):43–50. doi:10.20982/tqmp.03.2.p043
   Google Scholar
• Onyema Eledo B. Assessment of some haemostatic parameters among diabetes mellitus patients in bayelsa state: a case study at the federal medical centre, Yenagoa. Eur J Clin Biomed Sci. 2017;3(5):91–96. doi:10.11648/j.ejcbs.20170305.12
   Google Scholar
• Dhule S, Gawali S. Platelet aggregation and clotting time in type 2 diabetic males. Natl J Physiol Pharm Pharmacol. 2014;4(2):121–123. doi:10.5455/njppp.2014.4.290920131
   Google Scholar
• Pujani M, Gahlawat H, Agarwal C, Chauhan V, Singh K, Lukhmana S. Platelet parameters: can they serve as biomarkers of glycemic control or development of complications in the evaluation of type 2 diabetes mellitus? Iraqi J Hematol. 2018;7(2):72–78. doi:10.4103/ijh.ijh_8_18
   Web of Science ®Google Scholar
• Biadgo B, Melku M, Mekonnen Abebe S, Abebe M. Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. DiabetesMetabSyndrObes. 2016;9:91–99. doi:10.2147/DMSO
   Google Scholar
• Dindar S, Cinemre H, Sengul E, Annakkaya A. Mean Platelet Volume is Associated with Glycaemic Control and Retinopathy in Patients with Type 2 Diabetes Mellitus. West Indian Med J. 62(6):519–523. doi: 10.7727/wimj.2012.284.
   Web of Science ®Google Scholar
• Akinsegun A, Olusola DA, Sarah J-O, et al. Mean platelet volume and platelet counts in type 2 Diabetes: mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria. Pan Afr Med J. 2014;18:42. doi:10.11604/pamj.2014.18.42.3651
   PubMedGoogle Scholar
• Citirik M, Beyazyildiz E, Simsek M, Beyazyildiz O, Haznedaroglu IC. MPV may reflect subclinical platelet activation in diabetic patients with and without diabetic retinopathy. Eye. 2015;29(3):376–379. doi:10.1038/eye.2014.298
   PubMed Web of Science ®Google Scholar
• Malachowska B, Tomasik B, Szadkowska A, et al. Altered Platelets’ morphological parameters in children with type 1 diabetes – a case-control study. BMC Endocr Disord. 2015;15(17):1–7. doi:10.1186/1472-6823-15-1
   Web of Science ®Google Scholar
• Isaac IZEO. Some Haematological Parameters in Patients with Type-1 Diabetes in Sokoto, North-Western Nigeria. J Blood Lymph. 2012;03(01):1–4. doi:10.4172/2165-7831.1000110
   Google Scholar
• Keating FK, Sobel BE, Schneider DJ. Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and patients with and without diabetes mellitus. Am J Cardiol. 2003;92(11):1362–1365. doi:10.1016/j.amjcard.2003.08.033
   PubMed Web of Science ®Google Scholar
• Chen X, Fang L, Lin H, et al. The Relationship between Type 2 Diabetes and Platelet Indicators. Iran J Public Health. 2017;46(6):1211–1216.
   Google Scholar
• Indranila KS. Molecular aspect correlation between glycated hemoglobin (hba1c), prothrombin time (pt) and activated partial thromboplastin time (aptt) on type 2 diabetes mellitus (t2dm). Indones J Clin Pathol Med Lab. 2016;23(1):1–6.
   Google Scholar
• Nnenna I, Obioma A. Evaluation of Haemostatic Parameters of Diabetic Patients Accessing Care in Some Selected Health Care Facilities in Port Harcourt Metropolis, Nigeria. Sci Technol. 2016;3(2):119–134.
   Google Scholar
• Ziaee A, Ghorbani A, Kalbasi S, Hejrati A, Moradi S. Association of hematological indices with prediabetes: A cross-sectional study. Electron Physician. 2017;9(9):5206–5211. doi:10.19082/5206
   PubMedGoogle Scholar